Ribbe, Achim (Qiagen 200602 BusDev Manager) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Germany |
Ribon, Denis (ArchiMed 201609 Founder + Managing Director before 3i 200904 Head European Healthcare) |
Managing Partner (investment firm) |
ArchiMed (Group) |
France |
Riboud, Franck (Danone 200707 CEO) |
Chief Executive Officer (CEO) |
Danone (Group) |
France |
Ricci, Paolo |
n. a. |
Merck (DE) (Group) |
Switzerland |
Richard, Louis-François (Air Liquide 202211 Medical Gases Europe Cluster VP) |
President/Director/Head Business Group/Unit/Division |
Air Liquide (Group) |
France |
Richard, Marie-Paule (AiCuris 201107 CMO) |
Chief Medical Officer (CMO) |
STRÜNGMANN Group (family Strüngmann) |
Germany |
Richards, Dan (Qiagen 202306 VP of Clinical Product Management at Qiagen Digital Insights) |
n. a. |
Qiagen (Group) |
United States (USA) |
Richards, Don (Pfizer 200803 Head Structure Elucidation Pfizer UK Analytical R&D) |
Research & Development Manager |
Pfizer (Group) |
United Kingdom (GB) |
Richardson, Douglas (Merck (US) 201704 Merck Research Laboratories) |
Researcher (industry) |
Merck (US) (MSD) (Group) |
United States (USA) |
Richardson, Ryan (BioNTech 202001– Chief Strategy Officer joined 2018 as SVP CorpDev + Strategy before JP Morgan London) |
Business Development Manager / Strategy Manager |
BioNTech (Group) |
Germany |
Richenburg, Alexandra (Alphabet 202205– Director of People Operations before Eigen Tehcnologies + Meridian LS) |
Human Resources Manager |
Alphabet (formerly Google) (Group) |
United Kingdom (GB) |
Richman, Eric I. (Gain Therapeutics 202007– CEO before Brace Pharma Capital + PharmAthene + MedImmune) |
Chief Executive Officer (CEO) |
Gain Therapeutics (Group) |
United States (USA) |
Richman, Michael (NextCure 2015– CEO + Founder before AstraZeneca/Amplimmune + Chiron + MedImmune + MacroGenics) |
Chief Executive Officer (CEO) |
NextCure Inc. (Nasdaq: NXTC) |
United States (USA) |
Richon, Victoria (Entact Bio 202212 CEO before Ribon Therapeutics + Sanofi + Epizyme + Merck (US) + Aton Pharma) |
Chief Executive Officer (CEO) |
Entact Bio (US) |
United States (USA) |
Richter, Andreas (Ayoxxa Biosystems 201501– CFO before Direvo Biotech + 4-Antibody) |
Chief Financial Officer (CFO) |
Ayoxxa (Group) |
Germany |
Richter, Christine (IO Biotech 202306– SVP Commercial + Program Lead before LEO Pharma + Takeda Oncology + Amgen) |
Chief Commercial Officer (CCO) |
IO Biotech (Group) |
Denmark |
Richter, Henrijette (Sofinnova Partners 201509 before Novo Group 201304 at Novo Seeds) |
Managing Partner (investment firm) |
Sofinnova (Group) |
France |
Richter, Karl (Bio-Gate AG 201104 CEO) |
Chief Executive Officer (CEO) |
Bio-Gate (Group) |
Germany |
Richter, Susanne (PerkinElmer 201404 Marketing Communication Specialist Environmental Health) |
Public Relations Manager / Investor Relations Manager |
PerkinElmer (Group) |
Germany |
Richter, Thomas (Klocke Group 201410 Managing Director of BioPharma Translationsinstitut Dessau) |
Managing Director |
Klocke (Group) |
Germany |
Richter, Wolfgang (Tube Pharmaceuticals 201107 Managing Director / CEO) |
Managing Director |
Tube Pharmaceuticals GmbH |
Austria |
Ricken, Hans Joachim (Temmler Group 200612 Owner) |
n. a. |
Temmler (Group) |
Germany |
Ricker, Mathias (Wallinger Ricker Schlotter Trastmann 201409 Patent Attorney + Founding Partner) |
Patent Attorney |
Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte (WRST) |
Germany |
Rickert, Jörn (CorTec GmbH 201011 Managing Director) |
Managing Director |
CorTec GmbH |
Germany |
Ricks, Claude (SQI Diagnostics 201110 CEO) |
Chief Executive Officer (CEO) |
SQI Diagnostics Inc. |
Canada |
Ridder, Ruediger (mtm laboratories –200707– CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Roche (Group) |
Germany |
Ridgway, Peter (Reach Separations 201403 Business Development Director + Co-Founder) |
Business Development Manager / Strategy Manager |
CatSci (Group) |
United Kingdom (GB) |
Ridinger, Richard (Lonza 201205–201902 CEO before Cognis 11 years + Henkel 14 years RETIRED 3/19) |
Chief Executive Officer (CEO) |
Lonza (Group) |
Switzerland |
Riebel, Sonja (Accovion 201504 Marketing + Communication) |
Sales Manager / Marketing Manager |
Clinipace (Group) |
Germany |
Ried, Georg (Bavaria (govt) 201607 Managing Director of Bayern Kapital) |
Managing Director |
Numares (Group) |
Germany |
Riedel, Norbert (Baxter 200103– CSO joined Baster 1998 before Hoechst Marion Roussel) |
Advisory Board member |
Baxter (Group) |
United States (USA) |
Riedemann, Niels C. (InflaRx 200803 Managing Director + founder) |
Managing Director |
InflaRx (Group) |
Germany |
Riedl, Claudia (Gutjahr-Löser) (MC Services 201710– Managing Director before MorphoSys 2002–2017 + Cassiopeia + DB) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
Rieger, Eva-Maria (Omnilab (D) 200903 Public Relations & Communications Manager) |
Public Relations Manager / Investor Relations Manager |
Omnilab (DE) (Group) |
Germany |
Rieger, Markus (Going Public Media AG 202112 CEO + Founder) |
Chief Executive Officer (CEO) |
GoingPublic Media AG (FSE: WKN 761 210) |
Germany |
Riehle, Karolin (Eckert & Ziegler 202212 Investor Relations + PR) |
Public Relations Manager / Investor Relations Manager |
Eckert & Ziegler (Group) |
Germany |
Riemann, Angelica (Agilent –202411– continues as President of CrossLab Group as 25y Agilent veteran) |
President/Director/Head Business Group/Unit/Division |
Agilent (Group) |
United States (USA) |
Riemann, Gunnar (Bayer HealthCare 200603) |
Consultant (economic/technology) |
Bayer (Group) |
Germany |
Riemer, Helge (Epimune GmbH 201805 Managing Director) |
Managing Director |
Epimune GmbH |
Germany |
Riermeier, Thomas (Evonik 202003 SVP + General Manager for Health Care business line) |
General Manager (management) |
Evonik (Group) |
Germany |
Ries, Marco (ProteinDistillery 202403 Managing Director + Co-Founder) |
Managing Director |
ProteinDistillery GmbH |
Germany |
Ries, Michael (Cube Biotech 202501 Head of Sales + Marketing) |
Sales Manager / Marketing Manager |
Cube Biotech (Group) |
Germany |
Ries, Stefan (Disco Pharmaceuticals 202401– CSO before Roche + Versant Ventures) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Disco Pharmaceuticals (Group) |
Germany |
Riesenhuber, Heinz (Evotec Biosystems 199906 Chairman Supervisory Board) |
Advisory Board member |
Evotec (Group) |
Germany |
Riesmeier, Jörg (Direvo Industrial Biotechnology 201005 CEO– before COO since 201001 before LSP General Partner) |
Chief Executive Officer (CEO) |
EQT (Wallenberg family) (Group) |
Netherlands |
Riesner, Detlev (Evotec Biosystems 199906 Scientific Advisory Board + Qiagen Co-Founder) |
Advisory Board member |
Evotec (Group) |
Germany |
Riethmüller, Christoph (Serend-ip GmbH 2009– Managing Director + Founder) |
Managing Director |
Serend-ip GmbH |
Germany |
Rigaud, Olivier (Corbion 202010 CEO) |
Chief Executive Officer (CEO) |
Corbion (Group) |
Netherlands |
Rigby, Peter (Informa 1988–201312 CEO joined 1983 retired 12/13) |
Chief Executive Officer (CEO) |
Informa (Group) [NEW] |
Switzerland |
Rigg, John (Exelead 202201 CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
United States (USA) |
Righetti, Erin (CG Life 201709– Associate Director of Content before EBD Group) |
Public Relations Manager / Investor Relations Manager |
CG Life (Group) |
United States (USA) |
Rigler, Rudolf (Evotec Biosystems 199906 Scientific Advisory Board) |
Advisory Board member |
Evotec (Group) |
Germany |
Riley, Jeffrey (Gain Therapeutics 201909– Independent Board Director formerly SKB + Pfizer + Queensland Biocapital Fund) |
Board member, non-executive |
Gain Therapeutics (Group) |
Switzerland |
Riley, Mike (Catalent 201805 VP + General Manager of Drug Substance + Bioanalytical Services at Catalent Biologicals) |
General Manager (management) |
Catalent (Group) |
United States (USA) |
Riley, Nicole (ADC Therapeutics 202307 Media Relations) |
Public Relations Manager / Investor Relations Manager |
ADC Therapeutics (Group) |
Switzerland |
Riley, Ray (Syngenta Seeds 200705 Head Product Development) |
Research & Development Manager |
Syngenta (Group) |
Switzerland |
Rill, Stefan (Phytolutions 200806–201208 Managing Director CBO + Co-Founder NO NORE Managing Director since 8/12) |
Managing Director |
Phytolutions GmbH |
Germany |
Rindermann, Alexandra (Aska Biotech GmbH 202207 Managing Director) |
Managing Director |
Aska Biotech GmbH |
Germany |
Rinecker, Markus (Mbiomics 202303 Managing Director formerly Definiens 201210 CFO) |
Managing Director |
Mbiomics GmbH |
Germany |
Ring, Robert H. (Kaerus Bioscience 202404 CEO) |
Chief Executive Officer (CEO) |
Kaerus Bioscience Ltd. |
United Kingdom (GB) |
Ringel, Michael (Boston Consulting Group 202001 Managing Director + Senior Partner) |
Consultant (economic/technology) |
Boston Consulting Group (BCG) |
United States (USA) |
Rinke, Alexander (Celonis 202106 Co-CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Celonis (Group) |
Germany |
Rinn, Stefan (Boehringer Ingelheim 201403– Country Head Germany + Managing Director BI Pharma GmbH joined 1987) |
Managing Director |
Boehringer Ingelheim (Group) |
Germany |
Rinner, Oliver (Biognosys 202109 CEO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Bruker (Group) |
Switzerland |
Rinnert, Jan (Heraeus 201405 Chairman of Board of Management) |
Managing Director |
Heraeus (Group) |
Germany |
Rinsch, Chris (Amazentis 202209 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Amazentis S.A. |
Switzerland |
Ripplinger, Peter (Subitec GmbH 201207 Managing Director) |
Managing Director |
Subitec GmbH |
Germany |
Rippmann, Friedrich (Merck KGaA 200609 Director Bio- + Cheminformatics) |
n. a. |
Merck (DE) (Group) |
Germany |
Ripsens, Sybe Izaak (IWTK 201206 Managing Director) |
Managing Director |
Institut für Wissenschafts- und Technologiekommunikation GmbH (IWTK) |
Germany |
Risino, Amanda (Health Innovation Manchester 201807 Managing Director) |
Cluster Manager |
Health Innovation Manchester |
United Kingdom (GB) |
Risler, Christiane (SCPA GmbH 201705 Managing Director) |
Managing Director |
SCPA Software für Chromatographie und Prozess-Analytik GmbH |
Germany |
Risler, Wolfgang (SCPA GmbH 201705 Managing Director) |
Managing Director |
SCPA Software für Chromatographie und Prozess-Analytik GmbH |
Germany |
Risse, Bernd (Roche Diagnostics 200503) |
n. a. |
Roche (Group) |
Germany |
Ritsou, Elena (VectorY 202211– COO + BioGeneration Ventures 202211– Venture Partner before GammaDelta Tx + Ipsen) |
Chief Operating Officer (COO) |
VectorY (Group) |
Netherlands |
Ritter von Onciul, Andreas (SciMax 200209 CEO) |
Chief Executive Officer (CEO) |
SciMax Scientific Software Distribution |
Germany |
Ritter, Christiane (SeNostic GmbH 201412– CSO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Prosperodes GmbH |
Germany |
Ritter, Johannes (Roche 201106 Head Communications Roche Penzberg) |
Public Relations Manager / Investor Relations Manager |
Roche (Group) |
Germany |
Rittgen, Oliver (Bayer 201403 CEO of Bayer Nordic) |
Chief Executive Officer (CEO) |
Bayer Nordic SE |
Finland |
Rittner, Miriam (SiChem GmbH 2001–200902– Managing Director) |
Managing Director |
Sirius Fine Chemicals SiChem GmbH |
Germany |
Ritz, Sascha (Climedo Health 201705– Managing Director + Co-Founder) |
Managing Director |
Climedo Health GmbH |
Germany |
Riva, Alessandro (Transgene 202306– CEO before Chairman before Intima Bioscience + Ichnos Sciences + Gilead + Novartis) |
Research & Development Manager |
Mérieux (Group) |
France |
Rivet, Sarah (GIE Eurasanté 201709 Business Project Officer) |
Business Development Manager / Strategy Manager |
GIE Eurasanté |
France |
Rizo, Carolina Garcia (Immuneering 202103– CBO before Just Biotherapeutics + Thermo FIsher Scientific + Roche + Cepheid) |
Chief Business Officer (CBO) |
Immuneering Corporation |
United States (USA) |
Rizzo, Giovanni (Indaco Venture 202403 Partner at Indaco Bio Fund) |
Partner (venture partner) |
Indaco Venture (Group) |
Italy |
Rizzo, Thomas (EPFL 202404 Prof of Chemistry + Co-Founder of IsoSpe Analytics) |
Professor |
EPFL (Ecole Polytechnique Fédérale de Lausanne) |
Switzerland |
Rizzoli, Giancarlo (4D Lifetec 202310 CEO) |
Chief Executive Officer (CEO) |
4D Lifetec AG |
Switzerland |
Rizzuto, Carlo (Versant Ventures 201810 Partner) |
Partner (venture partner) |
Versant Ventures |
United States (USA) |
Robbers, Thomas (Nano-Bioanalytik-Zentrum-Münster 201107 Managing Director) |
Managing Director |
Nano-Bioanalytik-Zentrum GmbH (NBZ Münster) |
Germany |
Roberts, Christopher (Chris) (AC Immune 202401– promoted to CFO joined 2019) |
Chief Financial Officer (CFO) |
AC Immune S.A. (Nasdaq: ACIU) |
Switzerland |
Roberts, Tom (Rentschler 202309– President of Rentschler Biopharma Inc + General Manager US before Vitanova Biomedical) |
President/Director/Head Business Group/Unit/Division |
Rentschler (Group) |
United States (USA) |
Robertson, Lindon G. (Brooks Automation 201310– CFO before Graftech International + IBM Corp) |
Chief Financial Officer (CFO) |
Azenta (Group) |
United States (USA) |
Robertson, Neil (Techcomp 202405– CEO of Scion Instruments before Peak Scientific) |
Chief Executive Officer (CEO) |
Techcomp (Group) |
United Kingdom (GB) |
Robinson, James (Jim) (A2 Biotherapeutics 202404– CEO before Sumitomo/Urovant Sciences + Paragon Biosciences + Alkermes) |
Chief Executive Officer (CEO) |
A2 Biotherapeutics Inc. (A2 Bio) |
United States (USA) |
Robinson, Peter N. (Jackson Laboratory for Genomic Medicine 201611 Professor before Charité University Hospital Berlin) |
Professor |
Jackson Laboratory, The |
United States (USA) |
Robinson, Tim (LGC 201710 CEO) |
Chief Executive Officer (CEO) |
LGC (Group) |
United Kingdom (GB) |
Robroeks, Marcel (Steigerwald Arzneimittel GmbH 201305 Managing Director) |
Managing Director |
Bayer (Group) |
Germany |
Rocci, Mario (Solvias 202203 Chair + Advisor Water Street Healthcare Partners) |
Board member, non-executive |
Solvias (Group) |
Switzerland |
Rochat, Bertrand (Univ Lausanne 201410 CHUV) |
n. a. |
University of Lausanne (UNIL) |
Switzerland |
Rocher, Jean-Philippe (Addex 201802– Co-Head Disovery before Pierre Fabre + Addex + Devgen + GSK Japan + Batelle) |
management (personnel) |
Addex (Group) |
Switzerland |
Rocheteau, Pierre (Olgram 202401 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Olgram SAS |
France |